ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Neutral
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Very Weak
Earnings
Neutral
Growth
Earnings
Very Strong
Dividends
Neutral
Quality
Capital Efficiency
Weak
Balance Sheet
Neutral
Telephone
61.8.9244.0600
Address
86 Guthrie Street Osborne Park, Western Australia (WA) 6017
Description
XRF Scientific Ltd. manufactures and markets precious metal products, specialized chemicals and instruments for the scientific and analytical industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The Capital Equipment segment engages in the design, manufacture and service organization, specialized in automated fusion equipment, high temperature test and production furnaces, as well as general laboratory equipment. The Precious Metals segment manufactures products for the laboratory and platinum alloy markets. The Consumables segment produces and distributes consumables, chemicals and other supplies for analytical laboratories. The company was founded in 1972 and is headquartered in Osborne Park, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.08 - 2.16
Trade Value (12mth)
AU$78,778.00
1 week
14.06%
1 month
25%
YTD
12.57%
1 year
89.43%
All time high
2.16
EPS 3 yr Growth
68.80%
EBITDA Margin
26.80%
Operating Cashflow
$8m
Free Cash Flow Return
15.00%
ROIC
16.40%
Interest Coverage
55.70
Quick Ratio
2.10
Shares on Issue (Fully Dilluted)
140m
HALO Sector
Industrials
Next Company Report Date
25-Aug-25
Ex Dividend Date (est.)
12-Sep-24
Next Dividend Pay Date (est.)
27-Sep-24
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
18 February 25 |
Appendix 4D - Half-Year Report
×
Appendix 4D - Half-Year Report |
|
18 February 25 |
XRF announces record half-year result
×
XRF announces record half-year result |
|
18 February 25 |
February 2025 Investor Presentation
×
February 2025 Investor Presentation |
|
13 December 24 |
Completion of Labfit Acquisition
×
Completion of Labfit Acquisition |
|
13 December 24 |
Application for quotation of securities - XRF
×
Application for quotation of securities - XRF |
|
13 December 24 |
Cleansing Statement
×
Cleansing Statement |
|
12 December 24 |
Proposed issue of securities - XRF
×
Proposed issue of securities - XRF |
|
22 November 24 |
XRF Acquires Labfit
×
XRF Acquires Labfit |
|
04 November 24 |
Notification regarding unquoted securities - XRF
×
Notification regarding unquoted securities - XRF |
|
04 November 24 |
Change of Director's Interest Notice - V. Stazzonelli
×
Change of Director's Interest Notice - V. Stazzonelli |
|
28 October 24 |
Change of Director's Interest Notice - D. Brown
×
Change of Director's Interest Notice - D. Brown |
|
23 October 24 |
Response to ASX 3Y Query
×
Response to ASX 3Y Query |
|
23 October 24 |
Change of Director's Interest Notice - V. Stazzonelli
×
Change of Director's Interest Notice - V. Stazzonelli |
|
22 October 24 |
Change of Director's Interest Notice - D. Kiggins
×
Change of Director's Interest Notice - D. Kiggins |
|
22 October 24 |
Change of Director's Interest Notice - V. Stazzonelli
×
Change of Director's Interest Notice - V. Stazzonelli |
|
21 October 24 |
2024 AGM Presentation
×
2024 AGM Presentation |
|
21 October 24 |
Results of Meeting
×
Results of Meeting |
|
15 October 24 |
September 2024 Quarterly Trading Report
×
September 2024 Quarterly Trading Report |
|
30 September 24 |
Change of Director's Interest Notice - F. Grimwade
×
Change of Director's Interest Notice - F. Grimwade |
|
27 September 24 |
Update - Dividend/Distribution - XRF
×
Update - Dividend/Distribution - XRF |
|
27 September 24 |
Application for quotation of securities - XRF
×
Application for quotation of securities - XRF |
|
27 September 24 |
Change of Director's Interest Notice - V. Stazzonelli
×
Change of Director's Interest Notice - V. Stazzonelli |
|
16 September 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
|
04 September 24 |
Application for quotation of securities - XRF
×
Application for quotation of securities - XRF |
|
04 September 24 |
Notification of cessation of securities - XRF
×
Notification of cessation of securities - XRF |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
